"Medcan Australia (Medcan) is pleased to announce the receipt of its first cannabis cultivation permits from the ODC (Office of Drug Control).
This is by far Medcan’s most significant milestone to date and positions Medcan as one of only a few Australian licensed companies authorized to actually commence cultivation.
Medcan will now commence their cultivation program and are targeting the end of August 2020 to propagate their first seeds.
Medcan’s high tech indoor clean room cultivation, production and manufacture facility is a one of a kind in Australia. The facility is the largest licenced, indoor vertical cannabis cultivation facility in Australia with a combined canopy area once fully operational of over 1690m2. With precise control over environmental conditions, Medcan will be able to achieve up to 6.5 cultivation cycles per year allowing a conservative production capacity of over 6000 kg (6 tons).
This is a fundamental step towards Medcan’s goal of bringing the cost of medicinal cannabis products down for Australian patients. Medcan’s current range of MEDCAN branded products have recently received feedback from both doctor and patients as some of the highest quality products within the Australian medicinal cannabis space. Medcan’s GMP quality cultivation and manufacture facility aims to replicate this high-quality product by using the latest LED, HVACD, environmental control and extraction technology.
This milestone further positions Medcan as a front runner in the Australian medicinal cannabis space."